Docket #: S82-068
Hybridomas 3B12, an Anti-Human Leucocyte Reagent, and Hybridoma 4H9, an Anti-Human T Cell Reagent
Hybridoma 4H9 can be used as an antileukocyte reagent capable of recognizing T-cell leukemia and distinguishing it from other forms of acute leukemia. Hybridoma 3B12 can also be used as an antileukocyte reagent distinquishing leukemia lymphoms from other forms of malignancy.
Publications
- Blood Vol. 62, No 4
Similar Technologies
-
Monoclonal Antibodies Dreg-56, Dreg-55, Dreg-200, Against the Human Homing Receptor Lecam-1 S91-031Monoclonal Antibodies Dreg-56, Dreg-55, Dreg-200, Against the Human Homing Receptor Lecam-1
-
Monoclonal Antibody F59 S92-063Monoclonal Antibody F59
-
G-Protein-Linked Receptor-Transfected Lymphoid Cell as Tools for Drug Discovery and for Cellular Therapeutics S95-006G-Protein-Linked Receptor-Transfected Lymphoid Cell as Tools for Drug Discovery and for Cellular Therapeutics